Hikma Pharmaceuticals USA

NJ · United States · Reporting entity ID 100000136575

Total reported 2019–2025

$36.8M

#205 of 2,960 reporting companies — 0% of all reported industry payments

$5.04M in general payments across 26,523 records, plus $31.7M in research funding across 1,224 records.

How it breaks down

General payments $5,041,363

Research funding $31,725,658

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.